Back to search

Article

Synthesis, in vitro activity, and molecular docking of caffeic acid and resveratrol derivatives against Alzheimer's disease-related enzymes

2024-06-03

Abstract excerpt

<title>Abstract</title> <p>Alzheimer’s disease (AD) is the most common form of dementia affecting about 40 million people around the world. The number of people living with this ailment is expected to triple in the next 50 years due to the aging population and the lack of any effective treatment. In this work we have synthesized a group of three hybrid caffeic acid and a resveratrol derivatives (1-4), and we have...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
e29389b9-530f-53d3-bf8e-bea91d00240a
DOI
10.21203/rs.3.rs-4426314/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Synthesis, in vitro activity, and molecular docking of caffeic acid and resveratrol derivatives against Alzheimer's disease-related enzymesDOI 10.21203/rs.3.rs-4426314/v1
Exploring the therapeutic potential of natural compounds for Alzheimer's disease: Mechanisms of action and pharmacological propertiesSemantic proximity
Acetylcholinesterase Inhibitory Potential of Plant-Based Phenolics in the Treatment of Alzheimer's Disease: An In Silico ApproachSemantic proximity
A Novel multifunctional 5,6-dimethoxy-indanone-chalcone-carbamate hybrids alleviates cognitive decline in Alzheimer’s disease by dual inhibition of acetylcholinesterase and inflammationSemantic proximity
Caralluma dalzielii as a Potential Therapy for Alzheimer’s Disease: Insights from a Transgenic Drosophila melanogaster ModelSemantic proximity
Natural compounds that modulate BACE1-processing of amyloid-beta precursor protein in Alzheimer's disease.Semantic proximity
Ethyl caffeate ameliorated amyloid‐beta42 protein‐associated toxicity in PC12 cells andDrosophila melanogasterSemantic proximity
Curcumin/melatonin hybrid 5-(4-hydroxy-phenyl)-3-oxo-pentanoic acid [2-(5-methoxy-1H-indol-3-yl)-ethyl]-amide ameliorates AD-like pathology in the APP/PS1 mouse model.Semantic proximity
In-Silico Characterization and in-Vivo Validation of Albiziasaponin-A, Iso-Orientin, and Salvadorin Using a Rat Model of Alzheimer's DiseaseSemantic proximity
Curcumin in Alzheimer’s Disease: From Mechanistic Insights to Translational Challenges and Emerging Curcuminoid StrategiesSemantic proximity
Small-Molecule Amyloid Beta-Aggregation Inhibitors in Alzheimer's Disease Drug DevelopmentSemantic proximity
Network Pharmacology-guided Identification and Molecular Validation of Multi-Target Phytoconstituents from Gmelina arborea against Alzheimer’s DiseaseSemantic proximity
Therapeutic Options in Alzheimer’s Disease: From Classic Acetylcholinesterase Inhibitors to Multi-Target Drugs with Pleiotropic ActivitySemantic proximity
Select a neighboring publication to make it the new centre.